Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 24 , ISSUE S3 ( April, 2020 ) > List of Articles


“Petite” p value: A Researchers’ Dream! Readers, Beware of the Pit …

Sharada Mailankody

Keywords : Misuse, p value, Pitfalls, Statistics

Citation Information : Mailankody S. “Petite” p value: A Researchers’ Dream! Readers, Beware of the Pit …. Indian J Crit Care Med 2020; 24 (S3):140-141.

DOI: 10.5005/jp-journals-10071-23399

License: CC BY-NC 4.0

Published Online: 25-10-2015

Copyright Statement:  Copyright © 2020; The Author(s).


“What is the magic word for publication?” “The p value <0.05%” seems like an automatic answer from the researchers. Is that right? Let us take a quick peek at this seemingly simple gate-pass to publications!

  1. Pearson K. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philos Mag 1900;50(302):157–175. DOI: 10.1080/14786440009463897.
  2. Wasserstein RL, Lazar NA. The ASA's statement on p-values: context, process, and purpose. Am Stat 2016;70(2):129–133. DOI: 10.1080/00031305.2016.1154108.
  3. Nahm FS. What the p values really tell us. Korean J Pain 2017;30(4):241–242. DOI: 10.3344/kjp.2017.30.4.241.
  4. Ioannidis JPA. The proposal to lower P value thresholds to .005. JAMA 2018;319(14):1429–1430. DOI: 10.1001/jama.2018.1536.
  5. Chavalarias D, Wallach JD, Li AH, Ioannidis JP. Evolution of reporting P values in the biomedical literature, 1990-2015. JAMA 2016;315(11):1141–1148. DOI: 10.1001/jama.2016.1952.
  6. Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics 2011;90(3):891–904. DOI: 10.1007/s11192-011-0494-7.
  7. Nead KT, Wehner MR, Mitra N. The use of “Trend” statements to describe statistically nonsignificant results in the oncology literature. JAMA Oncol 2018;4(12):1778–1779. DOI: 10.1001/jamaoncol.2018.4524.
  8. JAMA Oncology, JAMA Network. Instructions for authors. Available at Last accessed on 16 March 2020.
  9. Adamina M, Tomlinson G, Guller U. Bayesian statistics in oncology. Cancer 2009;115(23):5371–5381. DOI: 10.1002/cncr.24628.
  10. Walsh M, Srinathan SK, McAuley DF, Mrkobrada M, Levine O, Ribic C, et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index. J Clin Epidemiol 2014;67(6):622–628. DOI: 10.1016/j.jclinepi.2013.10.019.
  11. Del Paggio JC, Tannock IF. The fragility of phase 3 trials supporting FDA-approved anticancer medicine: a retrospective analysis. Lancet Oncol 2019;20(8):1065–1069. DOI: 10.1016/S1470-2045(19)30338-9.
  12. Ventola CL. Mobile devices and apps for health care professionals: uses and benefits. P T 2014;39(5):356–364.
  13. Isaac T, Zheng J, Jha A. Use of UpToDate and outcomes in US hospitals. J Hosp Med 2012;2(2):85–90. DOI: 10.1002/jhm.944.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.